A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine
Status:
Completed
Trial end date:
2018-04-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy (headache freedom at 2 hours) of Timolol
0.5% ophthalmic solution compared to placebo in acute treatment of migraine headache. And to
assess the safety and tolerability of Timolol 0.5% ophthalmic solution in treatment of acute
migraine headache.